Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $72.66 Analyst target: $70.50 Upside: -2.97%
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
See the full interactive analysis & chart →Informational only — not investment advice.